Does ACE2 gene therapy improve glycemic control and prevent β-cell dysfunction in diabetic mice?
ACE2 represents a novel therapeutic target for preventing β-cell dysfunction and improving glycemic control in type 2 diabetes.
These findings identify ACE2 as a novel target for the prevention of β-cell dysfunction and apoptosis occurring in type 2 diabetes.
Bindom et al. (Mon,) studied this question.